|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
JPH0746994B2
(ja)
|
1984-10-04 |
1995-05-24 |
味の素株式会社 |
発酵法によるl−アミノ酸の製造法
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
CA2058820C
(en)
|
1991-04-25 |
2003-07-15 |
Kotikanyad Sreekrishna |
Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
|
|
JPH07501450A
(ja)
|
1991-11-29 |
1995-02-16 |
モンサント カンパニー |
環状ジグアニレート代謝酵素
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
EP0672161B1
(en)
|
1992-11-05 |
1999-09-22 |
Xyrofin Oy |
Recombinant method and host for manufacture of xylitol
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
JP3709564B2
(ja)
|
1994-08-30 |
2005-10-26 |
味の素株式会社 |
L−バリン及びl−ロイシンの製造法
|
|
JP3966583B2
(ja)
|
1997-06-23 |
2007-08-29 |
協和醗酵工業株式会社 |
発酵法によるl−アミノ酸の製造法
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
DK1578446T3
(en)
|
2002-11-07 |
2015-06-29 |
Immunogen Inc |
ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT
|
|
AU2011268498A1
(en)
|
2010-06-24 |
2013-01-31 |
Genoscience Pharma Sas |
Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
|
|
PH12013501201A1
(en)
*
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
NL2006359C2
(en)
|
2011-03-08 |
2012-04-24 |
Bird Engineering B V |
Genetically modified cell and process for use of said cell.
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
US9913627B2
(en)
*
|
2013-01-29 |
2018-03-13 |
Becton, Dickinson And Company |
Specimen collection container having a fluid separation chamber
|
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
|
AR098743A1
(es)
|
2013-12-13 |
2016-06-08 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-cd33
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
WO2016019300A1
(en)
|
2014-07-31 |
2016-02-04 |
Novartis Ag |
Subset-optimized chimeric antigen receptor-containing t-cells
|
|
EP3712171A1
(en)
|
2014-08-19 |
2020-09-23 |
Novartis AG |
Treatment of cancer using a cd123 chimeric antigen receptor
|
|
RU2751362C2
(ru)
*
|
2014-12-29 |
2021-07-13 |
Новартис Аг |
Способы получения экспрессирующих химерный антигенный рецептор клеток
|
|
CN113862292B
(zh)
*
|
2015-01-29 |
2024-12-27 |
明尼苏达大学董事会 |
嵌合抗原受体、组合物以及方法
|
|
CA3172801A1
(en)
|
2015-06-12 |
2016-12-15 |
Lentigen Technology, Inc. |
Method to treat cancer with engineered t-cells
|
|
ES2778651T3
(es)
|
2015-10-09 |
2020-08-11 |
Miltenyi Biotec Technology Inc |
Receptores de antígeno quimérico y métodos de uso
|
|
WO2017127306A1
(en)
|
2016-01-18 |
2017-07-27 |
Arisan Therapeutics |
Adamatane derivatives for the treatment of filovirus infection
|
|
AU2018227583B2
(en)
*
|
2017-03-03 |
2023-06-01 |
Obsidian Therapeutics, Inc. |
CD19 compositions and methods for immunotherapy
|
|
US11548893B2
(en)
|
2017-07-15 |
2023-01-10 |
Arisan Therapeutics Inc. |
Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
|
|
US11905528B2
(en)
*
|
2017-10-12 |
2024-02-20 |
Icell Gene Therapeutics Inc. |
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
|
|
CN111886008B
(zh)
|
2017-10-18 |
2024-05-31 |
港大科桥有限公司 |
用于抗mers-冠状病毒治疗的组合物和方法
|
|
CN108219004A
(zh)
*
|
2018-02-08 |
2018-06-29 |
吉林省拓华生物科技有限公司 |
双特异嵌合抗原受体修饰的t细胞、其制备方法及用途
|
|
IL321548A
(en)
*
|
2018-05-22 |
2025-08-01 |
Immunitybio Inc |
Recombinant NK cells expressing a chimeric antigen receptor (CAR) for epsilon-FC and uses thereof
|
|
WO2020055368A2
(en)
|
2018-09-12 |
2020-03-19 |
Istanbul Medipol Universitesi |
Usage of terpenic coumarin derived molecules in treating viral diseases
|
|
AU2019377461A1
(en)
*
|
2018-11-06 |
2021-05-27 |
Washington University |
Chimeric antigen receptor memory-like (CARML) NK cells and methods of making and using same
|
|
KR20210137085A
(ko)
*
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
US20220152110A1
(en)
*
|
2019-03-22 |
2022-05-19 |
The Regents Of The University Of California |
Switchable Chimeric Antigen Receptor-Engineered Human Natural Killer Cells
|
|
US20200308248A1
(en)
*
|
2019-03-26 |
2020-10-01 |
ST Phi Therapeutics |
Chimeric Natural Killer Cell Receptors and Method of Using Thereof
|